DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Gonitro is a drug marketed by Pohl Boskamp and is included in one NDA. There is one patent protecting this drug.
This drug has thirteen patent family members in six countries.
The generic ingredient in GONITRO is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
A generic version of GONITRO was approved as nitroglycerin by AM REGENT on May 24th, 1988.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Pohl Boskamp||GONITRO||nitroglycerin||POWDER;SUBLINGUAL||208424-001||Jun 8, 2016||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|